DisPATCH

all catalysts(0)

nothing on the calendar yet

News(10)

• STAT+: Why Schrödinger CEO Ramy Farid changed how he’s thinking about AI
  In this edition of STAT's AI Prognosis: Why Schrödinger CEO Ramy Farid is rethinking AI, Recursion's neuron map, and more health AI news.
  stat · 15d ago
• STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
  In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.
  stat · 22d ago
• STAT+: What is a ‘world model’? Nabla’s Alex LeBrun explains
  In this edition of AI Prognosis, Brittany Trang talks to Alex LeBrun, AI scribe company Nabla's executive chairman, about an alternative to LLMs
  stat · 29d ago
• STAT+: The whistleblower, The Lab, and the fine print
  In this AI Prognosis news roundup: Mayo's AI whistleblower, Sutter Health's reply to lawsuit over Abridge scribe, and more.
  stat · 1mo ago
• The risk of refusing a newborn’s vitamin K shot
  Health care workers on strike at Ebola treatment center, how to tackle the U.S. alcohol epidemic, and more Morning Rounds news
  stat · 1mo ago
• STAT+: The moment Anthropic convinced me it’s serious about science
  AI Prognosis: The release of Claude Science suggests big model makers are getting serious about real science, and not just flashy problems.
  stat · 1mo ago
• FDA says Zyn can market its pouches as safer than cigarettes
  The influence of the alcohol industry on policy, AI Claude for scientists, and more health news from Morning Rounds
  stat · 1mo ago
• What happens at a longevity festival?
  What happens at a longevity festival? On this week's STATus Report, Alex Hogan gets a dispatch from STAT's Sarah Todd.
  stat · 2mo ago
• Trump’s cuts to foreign aid are undermining the Ebola response, insiders say
  President Trump's cuts to foreign aid probably hampered the detection of the Ebola outbreak and the response to it.
  stat · 3mo ago
• #ASGCT26 dispatch: In vivo CAR-T is everywhere
  BOSTON — Greetings from Boston, where I’ve been on the ground covering the American Society of Gene & Cell Therapy’s annual meeting all week. It’s a crucial moment for the field. Genetic medicine d…
  endpoints · 3mo ago